PROMISCUOUS 2.0: A resource for drug-repositioning

29Citations
Citations of this article
67Readers
Mendeley users who have this article in their library.

Abstract

The development of new drugs for diseases is a time-consuming, costly and risky process. In recent years, many drugs could be approved for other indications. This repurposing process allows to effectively reduce development costs, time and, ultimately, save patients' lives. During the ongoing COVID-19 pandemic, drug repositioning has gained widespread attention as a fast opportunity to find potential treatments against the newly emerging disease. In order to expand this field to researchers with varying levels of experience, we made an effort to open it to all users (meaning novices as well as experts in cheminformatics) by significantly improving the entry-level user experience. The browsing functionality can be used as a global entry point to collect further information with regards to small molecules (∼1 million), side-effects (∼110 000) or drug-target interactions (∼3 million). The drug-repositioning tab for small molecules will also suggest possible drug-repositioning opportunities to the user by using structural similarity measurements for small molecules using two different approaches. Additionally, using information from the Promiscuous 2.0 Database, lists of candidate drugs for given indications were precomputed, including a section dedicated to potential treatments for COVID-19. All the information is interconnected by a dynamic network-based visualization to identify new indications for available compounds. Promiscuous 2.0 is unique in its functionality and is publicly available at http://bioinformatics.charite.de/promiscuous2.

References Powered by Scopus

DrugBank 5.0: A major update to the DrugBank database for 2018

5879Citations
N/AReaders
Get full text

SMILES, a Chemical Language and Information System: 1: Introduction to Methodology and Encoding Rules

5165Citations
N/AReaders
Get full text

Extended-connectivity fingerprints

4841Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Artificial intelligence to deep learning: machine intelligence approach for drug discovery

684Citations
N/AReaders
Get full text

LigAdvisor: A versatile and user-friendly web-platform for drug design

16Citations
N/AReaders
Get full text

Drug repositioning: A bibliometric analysis

15Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Gallo, K., Goede, A., Eckert, A., Moahamed, B., Preissner, R., & Gohlke, B. O. (2021). PROMISCUOUS 2.0: A resource for drug-repositioning. Nucleic Acids Research, 49(D1), D1373–D1380. https://doi.org/10.1093/nar/gkaa1061

Readers over time

‘20‘21‘22‘23‘2409182736

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 18

55%

Researcher 10

30%

Professor / Associate Prof. 3

9%

Lecturer / Post doc 2

6%

Readers' Discipline

Tooltip

Biochemistry, Genetics and Molecular Bi... 11

38%

Medicine and Dentistry 7

24%

Agricultural and Biological Sciences 6

21%

Pharmacology, Toxicology and Pharmaceut... 5

17%

Save time finding and organizing research with Mendeley

Sign up for free
0